{
  "html": "<table border=\"1px\" style=\"width: 100%;\"> <tbody><tr><td>&nbsp;</td>\n\t\t\t\t\t<th>PC Number</th>\n\t\t\t\t\t<th>Date</th>\n\t\t\t\t\t<th>Chapter</th>\n\t\t\t\t\t<th>Bill</th>\n\t\t\t\t\t<th>Dept</th></tr><tr><td style=\"min-width: 120px;\">&nbsp;</td><td>2020-1145</td><td>2020-12-24</td><td></td><td></td><td>,&nbsp; ,&nbsp; ,&nbsp; HC,&nbsp; ,&nbsp; </td></tr><tr><td>Act</td><td colspan=\"5\">Patent Act</td></tr><tr><td>Subject</td><td colspan=\"5\">Regulations amending the Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements), No. 2</td></tr><tr><td>Precis</td><td colspan=\"5\" id=\"precis\">Regulations Amending the REGULATIONS AMENDING THE PATENTED MEDICINES REGULATIONS (ADDITIONAL FACTORS AND INFORMATION REPORTING REQUIREMENTS), No.2  in order to delay the coming-into-force of the Amending Regulations until July 1, 2021 (1) to provide industry with additional time to prepare for the new reporting obligations as the COVID-19 pandemic continues to challenge all stakeholders; and (2) to provide industry with more than six months to further familiarize themselves with the Patented Medicines Prices Review Board's (PMPRB) final Guidelines, which were published on October 23, 2020, before the Amending Regulations came into force.</td></tr><tr><td>Registration</td><td colspan=\"5\" id=\"registration\"><strong>Registration: </strong>SOR/ 2020-0298  <strong>Publication Date:</strong> 2021-01-20</td></tr><tr><td>Attachments</td><td colspan=\"5\"><a href=\"attachment.php?attach=40158&amp;lang=en\">Attachment</a></td></tr></tbody></table>",
  "pcNumber": "2020-1145",
  "htmlHash": "c166e4d1010963bbbe4c617a06ddc52e",
  "attachments": [
    "40158"
  ],
  "date": "2020-12-24",
  "chapter": "",
  "bill": "",
  "department": ", , , HC, , ",
  "act": "Patent Act",
  "subject": "Regulations amending the Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements), No. 2",
  "precis": "Regulations Amending the REGULATIONS AMENDING THE PATENTED MEDICINES REGULATIONS (ADDITIONAL FACTORS AND INFORMATION REPORTING REQUIREMENTS), No.2  in order to delay the coming-into-force of the Amending Regulations until July 1, 2021 (1) to provide industry with additional time to prepare for the new reporting obligations as the COVID-19 pandemic continues to challenge all stakeholders; and (2) to provide industry with more than six months to further familiarize themselves with the Patented Medicines Prices Review Board's (PMPRB) final Guidelines, which were published on October 23, 2020, before the Amending Regulations came into force.",
  "registration": "Registration: SOR/ 2020-0298  Publication Date: 2021-01-20",
  "registration_type": "SOR",
  "registration_id": "2020-0298",
  "registration_publication_date": "2021-01-20"
}